Adlai Nortye ANL
NASDAQ ANL
$15.09 -0.67 (-4.25%)
At close: Oct 2, 2026 · 4:00 PM EDT

Adlai Nortye (ANL) Other Accumulated Expenses (2022 - 2026)

Updated

Adlai Nortye's Other Accumulated Expenses came in at $2.22 million for Q2 2026, down 54.4% from $4.88 million a year earlier.

Analysis

Adlai Nortye (ANL) Other Accumulated Expenses (2022 - 2026) Analysis & Trends

At the end of FY2025, Adlai Nortye's Other Accumulated Expenses was $3.74 million, up 9.6% from FY2024.

  • Other Accumulated Expenses carries a three-year compound annual growth rate of -1.2% (FY2022 to FY2025).
  • Going back by year, Other Accumulated Expenses was $3.41 million in FY2024 (-19.6%), $4.25 million in FY2023 (+9.5%) and $3.88 million in FY2022.
  • Year-over-year, Other Accumulated Expenses increased in two of the last four quarters, with an average decline of 8.9%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Adlai Nortye 518.14 Mn 418.85 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.22 Mn
Dec 31, 2025 3.74 Mn
Jun 30, 2025 4.88 Mn
Dec 31, 2024 3.41 Mn
Jun 30, 2024 3.79 Mn
Dec 31, 2023 4.25 Mn
Dec 31, 2022 3.88 Mn
API Access

Adlai Nortye Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ANL&period=max&api_key=YOUR_API_KEY